Cargando…

Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian Cancer

Undoubtedly ovarian cancer is a vexing, incurable disease for patients with recurrent cancer and therapeutic options are limited. Although the polycomb group gene, Bmi-1 that regulates the self-renewal of normal stem and progenitor cells has been implicated in the pathogenesis of many human malignan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Enfeng, Bhattacharyya, Sanjib, Szabolcs, Annamaria, Rodriguez-Aguayo, Cristian, Jennings, Nicholas B., Lopez-Berestein, Gabriel, Mukherjee, Priyabrata, Sood, Anil K., Bhattacharya, Resham
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061867/ https://www.ncbi.nlm.nih.gov/pubmed/21445297 http://dx.doi.org/10.1371/journal.pone.0017918

Ejemplares similares

Cystathionine Beta-Synthase (CBS) Contributes to Advanced Ovarian Cancer Progression and Drug Resistance
por: Bhattacharyya, Sanjib, et al.
Publicado: (2013)

Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer
por: Dhar Dwivedi, Shailendra Kumar, et al.
Publicado: (2016)

Src homology 2 (SH2) domain containing protein tyrosine phosphatase-1 (SHP-1) dephosphorylates VEGF Receptor-2 and attenuates endothelial DNA synthesis, but not migration*
por: Bhattacharya, Resham, et al.
Publicado: (2008)

Targeting BMI1 mitigates chemoresistance in ovarian cancer
por: Dey, Anindya, et al.
Publicado: (2022)

BMI1, a new target of CK2α
por: Banerjee Mustafi, Soumyajit, et al.
Publicado: (2017)

Designing Nanoconjugates to Effectively Target Pancreatic Cancer Cells In Vitro and In Vivo
por: Khan, Jameel Ahmad, et al.
Publicado: (2011)

Inhibiting the Growth of Pancreatic Adenocarcinoma In Vitro and In Vivo through Targeted Treatment with Designer Gold Nanotherapeutics
por: Kudgus, Rachel A., et al.
Publicado: (2013)

Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles
por: Xiong, Xunhao, et al.
Publicado: (2014)

When the chains do not break: the role of USP10 in physiology and pathology
por: Bhattacharya, Udayan, et al.
Publicado: (2020)

Therapeutic Silencing of Bcl-2 by Systemically Administered siRNA Nanotherapeutics Inhibits Tumor Growth by Autophagy and Apoptosis and Enhances the Efficacy of Chemotherapy in Orthotopic Xenograft Models of ER (−) and ER (+) Breast Cancer
por: Tekedereli, Ibrahim, et al.
Publicado: (2013)

Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges
por: Szymanowski, Wojciech, et al.
Publicado: (2023)

Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer
por: Lara, Olivia D., et al.
Publicado: (2020)

Regulation of hnRNPA1 by microRNAs controls the miR-18a–K-RAS axis in chemotherapy-resistant ovarian cancer
por: Rodriguez-Aguayo, Cristian, et al.
Publicado: (2017)

Role of cystathionine beta synthase in lipid metabolism in ovarian cancer
por: Chakraborty, Prabir K., et al.
Publicado: (2015)

Author Correction: Regulation of hnRNPA1 by microRNAs controls the miR-18a-K-RAS axis in chemotherapy-resistant ovarian cancer
por: Rodriguez-Aguayo, Cristian, et al.
Publicado: (2023)

Gold Nanoparticles sensitize pancreatic cancer cells to gemcitabine
por: Huai, Yanyan, et al.
Publicado: (2019)

CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis
por: Zhang, Shu, et al.
Publicado: (2015)

Silencing of Bmi-1 Gene Enhances Chemotherapy Sensitivity in Human Glioblastoma Cells
por: Hong, Yang, et al.
Publicado: (2015)

Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells
por: Gannon, Christopher J, et al.
Publicado: (2008)

Inorganic phosphate nanorods are a novel fluorescent label in cell biology
por: Patra, Chitta Ranjan, et al.
Publicado: (2006)

Back to the Future: Rethinking the Great Potential of lncRNA(S) for Optimizing Chemotherapeutic Response in Ovarian Cancer
por: Elsayed, Abdelrahman M., et al.
Publicado: (2020)

Inactivating Mutations of the IK Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy
por: Gao, Chao, et al.
Publicado: (2021)

Bmi-1: At the crossroads of physiological and pathological biology
por: Bhattacharya, Resham, et al.
Publicado: (2015)

Correction: Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
por: Cortez, Valerie, et al.
Publicado: (2012)

Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
por: Cortez, Valerie, et al.
Publicado: (2012)

Adrenergic regulation of monocyte chemotactic protein 1 leads to enhanced macrophage recruitment and ovarian carcinoma growth
por: Armaiz-Pena, Guillermo N., et al.
Publicado: (2014)

Small Non-Coding-RNA in Gynecological Malignancies
por: Dwivedi, Shailendra Kumar Dhar, et al.
Publicado: (2021)

Evaluation of I-TAC as a potential early plasma marker to differentiate between critical and non-critical COVID-19
por: Zhang, Yushan, et al.
Publicado: (2021)

Aptamers: Novel Therapeutics and Potential Role in Neuro-Oncology
por: Amero, Paola, et al.
Publicado: (2020)

Non-Coding RNAs: Foes or Friends for Targeting Tumor Microenvironment
por: Szymanowska, Anna, et al.
Publicado: (2023)

Experimental conditions influence the formation and composition of the corona around gold nanoparticles
por: Hossen, Md. Nazir, et al.
Publicado: (2021)

miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas
por: Tseng, Jill H., et al.
Publicado: (2017)

Patient-Derived Xenografts of High-Grade Serous Ovarian Cancer Subtype as a Powerful Tool in Pre-Clinical Research
por: Cybula, Magdalena, et al.
Publicado: (2021)

Metabolic shifts toward glutamine regulate tumor growth, invasion and bioenergetics in ovarian cancer
por: Yang, Lifeng, et al.
Publicado: (2014)

Targeted Silencing of Elongation Factor 2 Kinase Suppresses Growth and Sensitizes Tumors to Doxorubicin in an Orthotopic Model of Breast Cancer
por: Tekedereli, Ibrahim, et al.
Publicado: (2012)

Cystathionine β-Synthase Is Necessary for Axis Development in Vivo
por: Prabhudesai, Shubhangi, et al.
Publicado: (2018)

Corrigendum: Cystathionine β-Synthase Is Necessary for Axis Development in vivo
por: Prabhudesai, Shubhangi, et al.
Publicado: (2018)

The deubiquitinase USP10 protects pancreatic cancer cells from endoplasmic reticulum stress
por: Bhattacharya, Udayan, et al.
Publicado: (2022)

The neurotransmitter dopamine modulates vascular permeability in the endothelium
por: Bhattacharya, Resham, et al.
Publicado: (2008)

Emerging Trends in Neoadjuvant Chemotherapy for Ovarian Cancer
por: Patel, Ami, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2ur58dph4alf91sdgr9r28k03s